News

Article: Me, We and RWE. The Importance of Designing for the Patient First.

Bruce Hellman, uMotif CEO, and long-time collaborators Helen Matthews from The Cure Parkinson's Trust and Jessica Morris from OurBrainBank talk to Applied Clinical Trials

London, UK. 18th December 2018. Real World Evidence (RWE) is a subject of increasing discussion and implementation in clinical research, supplementing traditional clinical trials and offering the potential for better treatments with a faster route-to-market.

Perhaps less-discussed is the potential for RWE to aid another emerging priority in research design: that of patient centricity, which is rapidly becoming a priority for sponsors as well as a common call from patient advocates.

In this Q&A, Bruce, Jessica and Helen offer their perspectives on the priorities, opportunities, and challenges of patient centricity in real-world evidence collection:

Read the full article.